{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:26:06Z","timestamp":1775975166291,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bpobgyn.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T03:38:29Z","timestamp":1616557109000},"page":"96-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Future vaccines in pregnancy"],"prefix":"10.1016","volume":"76","author":[{"given":"D.","family":"Vress","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpobgyn.2021.03.009_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2018.12.025","article-title":"Malaria vaccine trials in pregnant women: an imperative without precedent","volume":"37","author":"Healy","year":"2019","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.bpobgyn.2021.03.009_bib2","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1016\/j.vaccine.2012.12.080","article-title":"A\u00a0Maternal vaccine against group B Streptococcus: past, present, and future","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.bpobgyn.2021.03.009_bib3","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib4","series-title":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) maternal Group B Streptococcus in pregnancy: screening and management (C-Obs 19)","year":"2019"},{"issue":"24","key":"10.1016\/j.bpobgyn.2021.03.009_bib5","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.03.009_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2051013615579869","article-title":"Group B Streptococcus vaccine: state of the art","volume":"3","author":"Nuccitelli","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.03.009_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(15)00484-3","article-title":"Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial","volume":"16","author":"Heyderman","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"20","key":"10.1016\/j.bpobgyn.2021.03.009_bib9","first-page":"30451","article-title":"Group B streptococcus vaccines: one step further","volume":"S1473\u20133099","author":"Berner","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.03.009_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.bpobgyn.2021.03.009_bib11","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.vaccine.2019.04.098","article-title":"Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women","volume":"37","author":"Hause","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.03.009_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anai.2020.03.017","article-title":"The journey to a respiratory syncytial virus vaccine","volume":"125","author":"Mejias","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2021.03.009_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2021.03.009_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/thoraxjnl-2018-212212","article-title":"Respiratory syncytial virus (RSV): a scourge from infancy to old age","volume":"74","author":"Coultas","year":"2019","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.bpobgyn.2021.03.009_bib15","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Mu\u0148oz","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.bpobgyn.2021.03.009_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00030-18","article-title":"Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections","volume":"92","author":"Permar","year":"2018","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2021.03.009_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"50","key":"10.1016\/j.bpobgyn.2021.03.009_bib18","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.bpobgyn.2021.03.009_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward development of a vaccine against congenital cytomegalovirus infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/314951","article-title":"A\u00a0canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)","volume":"180","author":"Adler","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","article-title":"Zika virus vaccine development: progress in the face of new challenges","volume":"70","author":"Diamond","year":"2019","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.03.009_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/tropicalmed4030104","article-title":"Zika vaccine development \u2013 current progress and challenges for the future","volume":"4","author":"Maslow","year":"2020","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib24","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In\u00a0vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunization with a prMEnv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"NPJ Vaccine"},{"issue":"1","key":"10.1016\/j.bpobgyn.2021.03.009_bib25","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1038\/s41467-019-13589-1","article-title":"Maternal vaccination and protective immunity against Zika virus vertical transmission","volume":"10","author":"Shan","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.bpobgyn.2021.03.009_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/microorganisms7060179","article-title":"Malaria: the past and the present","volume":"7","author":"Talapko","year":"2019","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.bpobgyn.2021.03.009_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2352-4642(20)30099-7","article-title":"Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs","volume":"4","author":"Saito","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"10.1016\/j.bpobgyn.2021.03.009_bib28","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/microorganisms8111748","article-title":"Diversify and conquer: the vaccine escapism of Plasmodium falciparum","volume":"8","author":"Pance","year":"2020","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.bpobgyn.2021.03.009_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (MosquirixTM): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum Vaccines Immunother"},{"issue":"10233","key":"10.1016\/j.bpobgyn.2021.03.009_bib30","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(20)30815-1","article-title":"The history of the RTS,S\/AS01 malaria vaccine trial","volume":"395","author":"Keating","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ebiom.2019.03.010","article-title":"Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC","volume":"42","author":"Ch\u00eane","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.03.009_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1473-3099(19)30739-X","article-title":"PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study","volume":"20","author":"Sirima","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.bpobgyn.2021.03.009_bib33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","article-title":"First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, A vaccine candidate to prevent pregnancy-associated malaria","volume":"69","author":"Mordm\u00fcller","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.bpobgyn.2021.03.009_bib34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/14760584.2019.1698952","article-title":"Ebola vaccine trials: progress in vaccine safety and immunogenicity","volume":"18","author":"Matz","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.bpobgyn.2021.03.009_bib35","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1016\/S1473-3099(20)30194-8","article-title":"Pregnancy and breastfeeding in the context of Ebola: a systematic review","volume":"20","author":"Foeller","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8207","key":"10.1016\/j.bpobgyn.2021.03.009_bib36","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(80)92352-1","article-title":"Inactivated vaccine for Ebola virus efficacious in Guinea pig model","volume":"316","author":"Lupton","year":"1980","journal-title":"Lancet"},{"issue":"35 Pt A","key":"10.1016\/j.bpobgyn.2021.03.009_bib37","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1016\/j.vaccine.2017.05.097","article-title":"Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic","volume":"35","author":"Coller","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.03.009_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"A\u00a0replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"issue":"10069","key":"10.1016\/j.bpobgyn.2021.03.009_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.bpobgyn.2021.03.009_bib40","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/infdis\/jiy020","article-title":"The Sierra Leone trial to introduce a vaccine against Ebola: an evaluation of rVSV\u0394G-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak","volume":"217","author":"Samai","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib41","series-title":"Benefits risk analysis of vaccination of pregnant women with rVSV-ZEBOV as part of expanded access programme","author":"Edmunds","year":"2018"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib42","author":"World Health Organization"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib43","doi-asserted-by":"crossref","first-page":"585354","DOI":"10.3389\/fimmu.2020.585354","article-title":"A\u00a0review of the progress and challenges of developing a vaccine for COVID-19","volume":"11","author":"Sharma","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib44","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.eclinm.2020.100446","article-title":"SARs-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes","volume":"25","author":"Khalil","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"10269","key":"10.1016\/j.bpobgyn.2021.03.009_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","article-title":"Oxford-AstraZeneca COVID-19 vaccine efficacy","volume":"397","author":"Knoll","year":"2020","journal-title":"Lancet"},{"issue":"10269","key":"10.1016\/j.bpobgyn.2021.03.009_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.bpobgyn.2021.03.009_bib48","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10252","key":"10.1016\/j.bpobgyn.2021.03.009_bib49","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S0140-6736(20)31822-5","article-title":"COVID-19 vaccines and neglected pregnancy","volume":"396","author":"Dashraath","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2021.03.009_bib50","unstructured":"Royal college of Obstetricians & Gynaecologists. Coronavirus (COVID-19) infection in pregnancy. Version 12. Published 14 October 2020."},{"issue":"5","key":"10.1016\/j.bpobgyn.2021.03.009_bib51","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000001150","article-title":"Ethical considerations for including women as research participants. ACOG committee opinion number 646","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2021.03.009_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4155\/cli.13.132","article-title":"The challenges of pregnancy in clinical trials for vaccines","volume":"4","author":"Munoz","year":"2014","journal-title":"Clin Invest"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693421000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693421000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:12:26Z","timestamp":1761498746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693421000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":52,"alternative-id":["S1521693421000481"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.03.009","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future vaccines in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}